Sofosbuvir & Ledipasvir Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 400 mg+ 90 mg
Reference Brands: Harvoni (USA/EU/UK)
Category: Anti Viral
The salt combination Sofosbuvir / Ledipasvir is used for the treatment of Hepatitis C, HIV, Liver Cancer, Chronic Hepatitis C Virus and other conditions. Sofosbuvir & Ledipasvir Tablets is available in Tablets and strengths such as 400 mg+ 90 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sofosbuvir & Ledipasvir Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sofosbuvir & Ledipasvir Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Sofosbuvir / Ledipasvir is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Hepatitis C · HIV · Liver Cancer · Chronic Hepatitis C Virus Sofosbuvir / Ledipasvir Working, Mechanism of Action and Pharmacology Sofosbuvir / Ledipasvir improves the patient's condition by performing the following functions: · Inhibiting the replication of virus in the body. · Helping the immune system in fighting against the infection.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sofosbuvir & Ledipasvir is used for the treatment of chronic hepatitis C virus (HCV) infection, primarily genotype 1. It helps reduce viral load and supports the complete clearance of the virus from the body. It is often used as a once-daily oral combination therapy.
Sofosbuvir & Ledipasvir is made from two antiviral agents: Sofosbuvir, a nucleotide analog polymerase inhibitor, and Ledipasvir, an NS5A inhibitor. Together, they block viral replication and prevent the virus from multiplying in the body.
The most commonly known trade name for this combination is Harvoni.
Harvoni is originally manufactured by Gilead Sciences. Several pharmaceutical companies also manufacture generic versions.
The generic name is Sofosbuvir and Ledipasvir.
The primary brand name is Harvoni, with several additional brand names available in different markets for generic versions.
It is manufactured in multiple regions, including the United States by Gilead Sciences and in India by various licensed generic manufacturers under voluntary licensing agreements.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
